The evolution of Harris’ stances on health care, fracking, Supreme Court
Vice President Kamala Harris’ stances on some issues have evolved in the past four years since her first run for the presidency.
Similar Posts
The 5 biggest political turkeys ripped by conservatives this year and more top headlines
1. Democrats find themselves on the short end of the stick. 2. State reportedly plans to bus illegal migrants directly to ICE instead of sanctuary cities. 3. Workers at online retail giant set to strike on busiest shopping days of the year. ‘EVERYBODY’S EXHAUSTED’ – Reporters from liberal outlets reveal they’re dreading Trump’s return to…
Sharad Pawar names 45 nominees in 1st list; NCP vs NCP in 13 seats
NCP (SCP), led by Sharad Pawar, announced its first list of candidates for the Maharashtra assembly polls, including 11 of its 12 sitting MLAs. The faction will compete against Ajit Pawar’s NCP in 13 key constituencies, including Baramati, highlighting internal party strife. The election outcome will determine the dominant faction in western Maharashtra.
Morning Glory: California’s catastrophe
“President Trump is the right person at the right time to tackle this problem. He is a developer, thinks big, and understands the public/private tensions,” my old boss in the Reagan White House Counsel’s Office, Richard Hauser, suggested when I began to grapple with the enormity of the challenge facing Los Angeles. I practiced land…
‘BJP workers, Delhi Police harassing AAP volunteers’: Kejriwal writes to EC
Arvind Kejriwal, chief of Aam Aadmi Party, wrote to the Election Commission of India alleging that AAP volunteers are being harassed and intimidated by BJP workers and Delhi Police. He highlighted multiple incidents where party workers were detained on baseless charges or assaulted, including an attack on his convoy.
Phase three clinical trial of India’s own dengue vaccine, DengiAll, initiated
India’s first phase-three trial for an indigenous tetravalent dengue vaccine, DengiALL, was initiated by Panacea Biotec. Conducted across 19 sites, the trial involves over 10,335 healthy adults. The vaccine aims to address all four dengue serotypes. The Union Health Minister J P Nadda highlighted its significance in combating dengue and enhancing India’s vaccine development capabilities.
